Millennium Management’s TherapeuticsMD TXMD Stock Holding History

Millennium Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,000	Closed	-$866K	–	3843
2016 Q4	$866K	Sell	3,000 -1,000	-25%	-$310K	﹤0.01%	2332
2016 Q3	$1.36M	Buy	4,000 +3,300	+471%	+$1.21M	﹤0.01%	2127
2016 Q2	$298K	Sell	700 -1,300	-65%	-$536K	﹤0.01%	2730
2016 Q1	$640K	Sell	2,000 -9,284	-82%	-$3.17M	﹤0.01%	2394
2015 Q4	$5.85M	Sell	11,284 -3,380	-23%	-$1.25M	0.01%	1256
2015 Q3	$4.3M	Buy	14,664 +6,400	+77%	+$2.27M	0.01%	1424
2015 Q2	$3.25M	Buy	8,264 +4,480	+118%	+$1.58M	0.01%	1645
2015 Q1	$1.15M	Buy	+3,784	New	+$924K	﹤0.01%	2251

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management's TXMD Position: Q1 2023 in Review

Millennium Management sold out of TherapeuticsMD (TXMD) in Q1 2023, closing a stake of 19,908 shares — an estimated $111K sold.

Millennium Management first reported a position in TXMD in Q2 2013 and held it in 33 quarters. The position peaked at $20.7M in Q2 2015. 41 funds tracked by Wall St. Rank hold TXMD as of Q1 2023.

Millennium Management reported no remaining TherapeuticsMD position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 19,908 TherapeuticsMD shares in Q1 2023, an estimated $111K.
Millennium Management first reported a position in TherapeuticsMD in Q2 2013 and held it in 33 quarters.
Millennium Management's TherapeuticsMD position peaked at $20.7M in Q2 2015.
41 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.